Litcius/Paper detail

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, Emilia Anis, Shepherd Roee Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jódar, Yeheskel Levy, Sharon Alroy‐Preis

2021The Lancet1,752 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Observational studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVaccination2019-20 coronavirus outbreakVirologyEnvironmental healthIntensive care medicineOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsSARS-CoV-2 detection and testing
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data | Litcius